140 related articles for article (PubMed ID: 16699368)
21. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.
Roskrow MA; Suzuki N; Gan Yj; Sixbey JW; Ng CY; Kimbrough S; Hudson M; Brenner MK; Heslop HE; Rooney CM
Blood; 1998 Apr; 91(8):2925-34. PubMed ID: 9531603
[TBL] [Abstract][Full Text] [Related]
22. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
[TBL] [Abstract][Full Text] [Related]
23. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
Gottschalk S; Edwards OL; Sili U; Huls MH; Goltsova T; Davis AR; Heslop HE; Rooney CM
Blood; 2003 Mar; 101(5):1905-12. PubMed ID: 12411306
[TBL] [Abstract][Full Text] [Related]
24. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness.
Takayama T; Nishioka Y; Lu L; Lotze MT; Tahara H; Thomson AW
Transplantation; 1998 Dec; 66(12):1567-74. PubMed ID: 9884241
[TBL] [Abstract][Full Text] [Related]
25. In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
Bollard CM; Gottschalk S; Huls MH; Molldrem J; Przepiorka D; Rooney CM; Heslop HE
Leuk Lymphoma; 2006 May; 47(5):837-42. PubMed ID: 16753867
[TBL] [Abstract][Full Text] [Related]
26. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
[TBL] [Abstract][Full Text] [Related]
27. SMAD4 and TGFβ are architects of inverse genetic programs during fate determination of antiviral CTLs.
Chandiran K; Suarez-Ramirez JE; Hu Y; Jellison ER; Ugur Z; Low JS; McDonald B; Kaech SM; Cauley LS
Elife; 2022 Aug; 11():. PubMed ID: 35942952
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
29. In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation.
Musk P; Szmania S; Galloway AT; Johnson K; Scott A; Guttman S; Bridges K; Bruorton M; Gatlin J; Garcia JV; Lamb L; Chiang KY; Spencer T; Henslee-Downey J; van Rhee F
J Immunother; 2001; 24(4):312-22. PubMed ID: 11565833
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
Quintarelli C; Vera JF; Savoldo B; Giordano Attianese GM; Pule M; Foster AE; Heslop HE; Rooney CM; Brenner MK; Dotti G
Blood; 2007 Oct; 110(8):2793-802. PubMed ID: 17638856
[TBL] [Abstract][Full Text] [Related]
31. Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.
Shah AH; Tabayoyong WB; Kundu SD; Kim SJ; Van Parijs L; Liu VC; Kwon E; Greenberg NM; Lee C
Cancer Res; 2002 Dec; 62(24):7135-8. PubMed ID: 12499244
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease.
Shah AH; Tabayoyong WB; Kimm SY; Kim SJ; Van Parijs L; Lee C
J Immunol; 2002 Oct; 169(7):3485-91. PubMed ID: 12244137
[TBL] [Abstract][Full Text] [Related]
33. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of Epstein-Barr virus-specific antigen peptide-activated cytotoxic T-cells treatment for refractory or recurrent angioimmunoblastic T-cell lymphoma: A prospective clinical observational study.
Bingjie W; Lihong W; Yongjin S; Huihui L; Jinping O; Xi'nan C
Hematol Oncol; 2020 Aug; 38(3):272-276. PubMed ID: 32083758
[TBL] [Abstract][Full Text] [Related]
35. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
[TBL] [Abstract][Full Text] [Related]
36. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of human EBV-specific cytotoxic T lymphocytes utilized for adoptive immunotherapy of EBV-induced lymphoproliferations in xenografted SCID mice.
Lacerda JF; O'Reilly RJ
Ann Oncol; 1997; 8 Suppl 2():137-40. PubMed ID: 9209657
[TBL] [Abstract][Full Text] [Related]
38. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
Savoldo B; Goss JA; Hammer MM; Zhang L; Lopez T; Gee AP; Lin YF; Quiros-Tejeira RE; Reinke P; Schubert S; Gottschalk S; Finegold MJ; Brenner MK; Rooney CM; Heslop HE
Blood; 2006 Nov; 108(9):2942-9. PubMed ID: 16835376
[TBL] [Abstract][Full Text] [Related]
39. Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growth.
Evans LS; Witte PR; Feldhaus AL; Nelson BH; Riddell SR; Greenberg PD; Lupton SD; Jones LA
Hum Gene Ther; 1999 Aug; 10(12):1941-51. PubMed ID: 10466628
[TBL] [Abstract][Full Text] [Related]
40. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells.
Takayama T; Tahara H; Thomson AW
Transplantation; 1999 Dec; 68(12):1903-9. PubMed ID: 10628772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
